Search

Search Constraints

You searched for: Author/Creator Cardinali, Barbara

Search Results

1. Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial. Issue 1 (February 2023)

2. Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial. (September 2020)

4. Increases in Tumor N‐Glycan Polylactosamines Associated with Advanced HER2‐Positive and Triple‐Negative Breast Cancer Tissues. Issue 1 (7th February 2019)

6. Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines. Issue 1 (December 2015)

7. Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines. Issue 1 (December 2015)

8. Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines. Issue 1 (December 2016)